BioHarvest Sciences Inc. Announces Closing of Oversubscribed Private Placement. Company Issues 15,449,829 Units at $0.40 per Unit for Gross Proceeds of $6,179,931.60 Biotech Investing
Gilead and the Human Rights Campaign Will Work Together to Combat HIV Epidemic and Promote Transgender Justice Biotech Investing
HempFusion Wellness Inc. Becomes Exclusive CBD and Probiotics Sponsor of Loenbro Motorsports for 2021 Racing Season Biotech Investing
WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland Biotech Investing
Bristol Myers Squibb Announces Positive Topline Results from Second Pivotal Phase 3 Psoriasis Study Showing Superiority of Deucravacitinib Compared to Placebo and Otezla® Biotech Investing
Eversea Confirms Launch of the World's First Organic Omega-3 DHA Supplement Across USA Biotech Investing
Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT "The Spirit Molecule" Biotech Investing
Bristol Myers Squibb Application for Zeposia® for the Treatment of Ulcerative Colitis Accepted for Filing with Priority Review by U.S. Food and Drug Administration Biotech Investing
Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone's Vaccine Platform Technology for HIV Cure Biotech Investing
